GC
PFE icon

Gould Capital’s Pfizer PFE Stock Holding History

Gould Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.1K Hold
1,000
– – 0.01% 122
2026
Q1 		$28.1K Hold
1,000
– – 0.02% 111
2025
Q4 		$24.9K Hold
1,000
– – 0.02% 110
2025
Q3 		$25.5K Hold
1,000
– – 0.02% 111
2025
Q2 		$24.2K Hold
1,000
– – 0.02% 107
2025
Q1 		$25.3K Hold
1,000
– – 0.02% 102
2024
Q4 		$26.5K Buy
1,000
+493
+97% +$13.4K 0.02% 109
2024
Q3 		$14.7K Buy
507
+7
+1% +$204 0.01% 137
2024
Q2 		$14K Hold
500
– – 0.01% 137
2024
Q1 		$13.9K Buy
+500
New +$13.9K 0.01% 134
2022
Q4 		– Sell
-40
Closed -$2K – 213
2022
Q3 		$2K Hold
40
– – ﹤0.01% 178
2022
Q2 		$2K Hold
40
– – ﹤0.01% 189
2022
Q1 		$2K Sell
40
-487
-92% -$25.3K ﹤0.01% 181
2021
Q4 		$31K Buy
+527
New +$26.1K 0.02% 105

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Gould Capital's PFE Position: Q2 2026 in Review

Gould Capital held its Pfizer (PFE) position steady in Q2 2026 at 1,000 shares worth $24.1K. The position accounts for 0.01% of the portfolio, ranked #122.

Gould Capital first reported a position in PFE in Q4 2021 and has held it in 14 quarters since. The position peaked at $31K in Q4 2021. 2,829 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Gould Capital held 1,000 shares of Pfizer worth $24.1K as of Q2 2026.
  • Gould Capital left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.01% of Gould Capital's portfolio in Q2 2026, its #122 holding.
  • Gould Capital first reported a position in Pfizer in Q4 2021 and has held it in 14 quarters since.
  • Gould Capital's Pfizer position peaked at $31K in Q4 2021.
  • 2,829 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Gould Capital's 13F filing for Q2 2026, filed 7 Aug 2026.